Clinical Trial Update: Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the outcome of secukinumab treatment in moderate to severe plaque psoriasis completed at a tertiary care hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED